-
公开(公告)号:US12195465B2
公开(公告)日:2025-01-14
申请号:US18497515
申请日:2023-10-30
Applicant: Kumquat Biosciences Inc.
Inventor: Baogen Wu , Pingda Ren , Zhiyong Chen , Yi Liu
IPC: C07D471/22 , A61K45/06 , C07D495/22 , C07D498/22
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US20240166641A1
公开(公告)日:2024-05-23
申请号:US18463134
申请日:2023-09-07
Applicant: Kumquat Biosciences Inc.
Inventor: Liansheng Li , Xiuwen Zhu , Pingda Ren , Jonathan Deane , Lomon So , Yi Liu
IPC: C07D417/14 , A61P35/00 , C07D417/04 , C07D471/04
CPC classification number: C07D417/14 , A61P35/00 , C07D417/04 , C07D471/04
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US20240109918A1
公开(公告)日:2024-04-04
申请号:US18311853
申请日:2023-05-03
Applicant: Kumquat Biosciences Inc.
Inventor: Xiaoming Li , Yuan Liu , Pingda Ren , Liansheng Li , Zhiyong Chen , Baogen Wu , Siling Zhao
IPC: C07D519/00 , A61P35/00 , C07D471/10 , C07D487/10
CPC classification number: C07D519/00 , A61P35/00 , C07D471/10 , C07D487/10
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US11912708B2
公开(公告)日:2024-02-27
申请号:US18328109
申请日:2023-06-02
Applicant: Kumquat Biosciences Inc.
Inventor: Baogen Wu , Pingda Ren , Zhiyong Chen , Yi Liu
IPC: C07D471/22 , A61K45/06 , C07D495/22 , C07D498/22
CPC classification number: C07D471/22 , A61K45/06 , C07D495/22 , C07D498/22
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US20240425522A1
公开(公告)日:2024-12-26
申请号:US18668025
申请日:2024-05-17
Applicant: Kumquat Biosciences Inc.
Inventor: Pingda Ren , Liansheng Li , Baogen Wu , Xiaoming Li , Zhiyong Chen , Siling Zhao , Yi Liu , Xiuwen Zhu
IPC: C07D519/00 , A61K31/519 , A61K31/551 , A61K31/553
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US20240398828A1
公开(公告)日:2024-12-05
申请号:US18669349
申请日:2024-05-20
Applicant: Kumquat Biosciences Inc.
Inventor: Liansheng Li , Xiuwen Zhu , Pingda Ren , Jonathan Deane , Lomon So , Yi Liu
IPC: A61K31/553 , A61K31/433 , A61K31/437 , A61K31/439 , A61K31/4439 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K45/06 , A61P37/04 , C07D285/06 , C07D417/10 , C07D417/14 , C07D471/08 , C07D487/10 , C07D491/107
Abstract: The present disclosure provides compounds and pharmaceutical compositions comprising the same. The compounds, pharmaceutical compositions thereof, and methods of using the same have a range of utilities as therapeutics, diagnostics, and research tools. The subject compositions and methods are particularly useful for potentiating immune response and/or applicable for treating cancer and other diseases.
-
公开(公告)号:US20240390389A1
公开(公告)日:2024-11-28
申请号:US18634495
申请日:2024-04-12
Applicant: Kumquat Biosciences Inc.
Inventor: Baogen Wu , Liansheng Li , Pingda Ren , Yi Liu , Siling Zhao , Xiaoming Li , Zhiyong Chen , Zhimin Zhu
IPC: A61K31/553 , A61K31/519 , A61P35/00 , C07D519/00
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of certain oncogenic proteins.
-
公开(公告)号:US20240208975A1
公开(公告)日:2024-06-27
申请号:US18497515
申请日:2023-10-30
Applicant: Kumquat Biosciences Inc.
Inventor: Baogen Wu , Pingda Ren , Zhiyong Chen , Yi Liu
IPC: C07D471/22 , A61K45/06 , C07D495/22 , C07D498/22
CPC classification number: C07D471/22 , A61K45/06 , C07D495/22 , C07D498/22
Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
-
公开(公告)号:US20230092294A1
公开(公告)日:2023-03-23
申请号:US17838068
申请日:2022-06-10
Applicant: Kumquat Biosciences Inc.
Inventor: Yi Liu , Jonathan Deane , Amy Strasner , Matthew R. Janes , Liansheng Li , Karen K. Wong , Pingda Ren
Abstract: The present disclosure provides compositions and methods for enhancing immunity (or immune response). The compositions and methods are particularly useful for potentiating immune response of a lymphoid cell. The compositions and methods are applicable for treating cancer and other diseases.
-
公开(公告)号:US20230044323A1
公开(公告)日:2023-02-09
申请号:US17838064
申请日:2022-06-10
Applicant: Kumquat Biosciences Inc.
Inventor: Yi Liu , Jonathan Deane , Amy Strasner , Liansheng Li , Matthew R. Janes , Karen K. Wong , Pingda Ren
IPC: A61K39/395 , A61K38/17 , A61K35/17 , A61K45/06 , A61P35/00
Abstract: The present disclosure provides compositions and methods for enhancing immunity (or immune response). The compositions and methods are particularly useful for potentiating immune response of a lymphoid cell. The compositions and methods are also applicable for treating cancer and other diseases.
-
-
-
-
-
-
-
-
-